Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | VAXX | Series A preferred stock | Nov 10, 2021 | Class A common stock | 3.57M | See footnote | F1, F2, F11 | |||||||
holding | VAXX | Series A preferred stock | Nov 10, 2021 | Class A common stock | 1.34M | See footnote | F3, F4, F11 | |||||||
holding | VAXX | Series A preferred stock | Nov 10, 2021 | Class A common stock | 2.36M | See footnote | F5, F6, F11 | |||||||
holding | VAXX | Series B preferred stock | Nov 10, 2021 | Class A common stock | 5.63M | See footnote | F7, F8, F11 | |||||||
holding | VAXX | Series A preferred stock | Nov 10, 2021 | Class A common stock | 15.2M | Direct | F9, F10, F11 |
Id | Content |
---|---|
F1 | The 3,570,201 shares of Series A preferred stock will convert into 2,294,473 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series A preferred stock. |
F2 | Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. |
F3 | The 1,341,050 shares of Series A preferred stock will convert into 861,857 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series A preferred stock. |
F4 | Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. |
F5 | The 2,361,626 shares of Series A preferred stock will convert into 1,517,754 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series A preferred stock. |
F6 | Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. |
F7 | The 5,625,000 shares of Series B preferred stock will convert into 3,615,038 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series B preferred stock. |
F8 | Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. |
F9 | The 15,152,627 shares of Series A preferred stock will convert into 9,738,192 shares of Class A common stock automatically upon closing of the initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of Series A preferred stock. |
F10 | Held by PML. PML GP I is the general partner of PML. |
F11 | Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |